Jacqueline Williams
Concepts (322)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Radiation Injuries | 7 | 2004 | 63 |
Why?
| Radiotherapy | 5 | 2003 | 73 |
Why?
| Lung | 8 | 1995 | 232 |
Why?
| Radiation Pneumonitis | 6 | 1995 | 12 |
Why?
| Aging | 4 | 2009 | 275 |
Why?
| Radiation Injuries, Experimental | 8 | 1994 | 37 |
Why?
| Pulmonary Fibrosis | 6 | 1996 | 48 |
Why?
| Whole-Body Irradiation | 4 | 1999 | 43 |
Why?
| Radiation-Protective Agents | 3 | 2003 | 28 |
Why?
| Cytokines | 8 | 1995 | 207 |
Why?
| Radiation Tolerance | 4 | 1999 | 37 |
Why?
| Information Services | 2 | 2003 | 21 |
Why?
| Radiobiology | 2 | 2009 | 9 |
Why?
| Surgical Procedures, Operative | 2 | 2003 | 77 |
Why?
| Radiation Protection | 1 | 2010 | 17 |
Why?
| Antineoplastic Agents | 3 | 2003 | 190 |
Why?
| Disease Models, Animal | 5 | 1998 | 349 |
Why?
| Research | 2 | 2009 | 124 |
Why?
| Nursing Care | 1 | 2008 | 10 |
Why?
| Nurses | 1 | 2008 | 19 |
Why?
| Terrorism | 1 | 2008 | 9 |
Why?
| Environmental Exposure | 2 | 2010 | 75 |
Why?
| Homeostasis | 1 | 2010 | 99 |
Why?
| Carotid Stenosis | 2 | 1999 | 33 |
Why?
| Hospitals | 1 | 2008 | 46 |
Why?
| Neoplasms | 3 | 2003 | 239 |
Why?
| Brain | 8 | 1994 | 305 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2010 | 119 |
Why?
| Cell Proliferation | 2 | 2010 | 227 |
Why?
| Emergency Medical Services | 1 | 2008 | 61 |
Why?
| Dose-Response Relationship, Radiation | 9 | 1988 | 85 |
Why?
| Animals | 38 | 1986 | 1031 |
Why?
| Mice, Inbred C57BL | 15 | 1995 | 318 |
Why?
| Lovastatin | 1 | 2004 | 13 |
Why?
| Mice | 27 | 1986 | 623 |
Why?
| Radiation Dosage | 8 | 1988 | 65 |
Why?
| Peripheral Vascular Diseases | 2 | 1999 | 26 |
Why?
| Brachytherapy | 3 | 1995 | 32 |
Why?
| Prostaglandin-Endoperoxide Synthases | 6 | 1998 | 66 |
Why?
| Cell Aging | 2 | 2010 | 31 |
Why?
| Keloid | 1 | 1999 | 4 |
Why?
| Skin | 5 | 1986 | 177 |
Why?
| Neoplasms, Radiation-Induced | 3 | 1986 | 31 |
Why?
| Humans | 23 | 1998 | 1856 |
Why?
| Tunica Intima | 4 | 1995 | 31 |
Why?
| Male | 26 | 1986 | 1553 |
Why?
| Isoenzymes | 5 | 1998 | 144 |
Why?
| Lung Injury | 3 | 1998 | 36 |
Why?
| Interleukin-1 | 5 | 1995 | 109 |
Why?
| Skin Neoplasms | 3 | 1986 | 97 |
Why?
| Hyperplasia | 7 | 1995 | 55 |
Why?
| Tumor Necrosis Factor-alpha | 5 | 1996 | 210 |
Why?
| Transforming Growth Factor beta | 4 | 1995 | 99 |
Why?
| Silicone Gels | 2 | 2010 | 6 |
Why?
| Balloon Dilation | 3 | 1998 | 42 |
Why?
| Interleukin-6 | 4 | 2001 | 145 |
Why?
| Encephalitis | 2 | 2002 | 29 |
Why?
| Blood-Brain Barrier | 1 | 1994 | 63 |
Why?
| Female | 16 | 1986 | 1643 |
Why?
| United States | 3 | 2008 | 604 |
Why?
| Biological Markers | 4 | 2001 | 262 |
Why?
| Survivors | 2 | 2010 | 45 |
Why?
| Age Distribution | 2 | 2010 | 127 |
Why?
| Adult | 9 | 1999 | 1317 |
Why?
| Antigens, CD11c | 1 | 2011 | 3 |
Why?
| Implant Capsular Contracture | 1 | 2011 | 4 |
Why?
| Thoracic Neoplasms | 2 | 2001 | 16 |
Why?
| Aspergillus fumigatus | 1 | 2011 | 5 |
Why?
| Tai Ji | 1 | 2011 | 8 |
Why?
| Breast Neoplasms | 2 | 2003 | 185 |
Why?
| Breast Implants | 1 | 2010 | 9 |
Why?
| Smad3 Protein | 1 | 2011 | 26 |
Why?
| Erythroid Cells | 1 | 2011 | 8 |
Why?
| Skull | 1 | 2011 | 48 |
Why?
| DNA Repair | 2 | 2002 | 47 |
Why?
| Mice, Inbred C3H | 8 | 1996 | 86 |
Why?
| Vascular Surgical Procedures | 2 | 2000 | 39 |
Why?
| Models, Animal | 1 | 2010 | 85 |
Why?
| Gene Expression Regulation | 3 | 2002 | 277 |
Why?
| Testicular Neoplasms | 1 | 2010 | 26 |
Why?
| Macrophages | 4 | 1998 | 148 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2010 | 39 |
Why?
| Radiation Oncology | 1 | 2009 | 11 |
Why?
| Rats | 6 | 1990 | 530 |
Why?
| Intercellular Adhesion Molecule-1 | 3 | 1997 | 51 |
Why?
| Microglia | 3 | 1999 | 29 |
Why?
| Young Adult | 2 | 2010 | 380 |
Why?
| Disaster Planning | 1 | 2008 | 7 |
Why?
| Faculty, Medical | 1 | 2009 | 45 |
Why?
| Survival Rate | 3 | 2004 | 250 |
Why?
| RNA, Messenger | 8 | 1996 | 394 |
Why?
| Cell Transformation, Neoplastic | 1 | 2010 | 86 |
Why?
| Recurrence | 3 | 1998 | 261 |
Why?
| Astrocytes | 4 | 1997 | 62 |
Why?
| Rats, Sprague-Dawley | 4 | 1995 | 257 |
Why?
| Teaching | 1 | 2009 | 89 |
Why?
| Muscle, Smooth, Vascular | 3 | 1999 | 59 |
Why?
| Fibroblast Growth Factor 2 | 2 | 1998 | 49 |
Why?
| Insulin | 1 | 2011 | 129 |
Why?
| Middle Aged | 8 | 2001 | 1161 |
Why?
| Aged | 7 | 2001 | 988 |
Why?
| Health Care Surveys | 1 | 2008 | 91 |
Why?
| T-Lymphocytes | 1 | 2011 | 182 |
Why?
| Infant | 2 | 2010 | 464 |
Why?
| Chemokines | 3 | 2002 | 48 |
Why?
| Radiation, Ionizing | 2 | 2002 | 21 |
Why?
| Silicosis | 1 | 2006 | 6 |
Why?
| Cyclooxygenase 2 | 6 | 1998 | 77 |
Why?
| Child, Preschool | 2 | 2010 | 554 |
Why?
| Cross-Sectional Studies | 1 | 2008 | 253 |
Why?
| Dinoprostone | 2 | 2002 | 55 |
Why?
| Antioxidants | 1 | 2008 | 84 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 145 |
Why?
| Dose-Response Relationship, Drug | 3 | 2001 | 431 |
Why?
| Silicon Dioxide | 1 | 2006 | 27 |
Why?
| Sulfonamides | 2 | 2002 | 74 |
Why?
| Clinical Competence | 1 | 2008 | 130 |
Why?
| Time Factors | 7 | 1996 | 896 |
Why?
| Internship and Residency | 1 | 2009 | 175 |
Why?
| Attitude of Health Personnel | 1 | 2008 | 165 |
Why?
| Inflammation | 2 | 2004 | 208 |
Why?
| Infant, Newborn | 1 | 2010 | 389 |
Why?
| Cell Differentiation | 1 | 2011 | 262 |
Why?
| Intestines | 1 | 2005 | 83 |
Why?
| Radiodermatitis | 1 | 2003 | 6 |
Why?
| Child | 2 | 2010 | 749 |
Why?
| Brain Edema | 1 | 2004 | 26 |
Why?
| Prostaglandins | 1 | 2004 | 41 |
Why?
| Questionnaires | 1 | 2008 | 360 |
Why?
| Risk Factors | 2 | 2002 | 555 |
Why?
| Respiration | 1 | 2004 | 78 |
Why?
| Flurothyl | 1 | 2003 | 3 |
Why?
| Adolescent | 2 | 2010 | 891 |
Why?
| Cyclooxygenase Inhibitors | 1 | 2003 | 47 |
Why?
| Mitosis | 1 | 2003 | 68 |
Why?
| Cyclin-Dependent Kinases | 1 | 2002 | 21 |
Why?
| Carotid Artery Injuries | 2 | 1998 | 17 |
Why?
| Cyclins | 1 | 2002 | 28 |
Why?
| Bone Neoplasms | 1 | 2004 | 83 |
Why?
| Receptors, Chemokine | 1 | 2002 | 24 |
Why?
| Iridium Radioisotopes | 2 | 1995 | 11 |
Why?
| Signal Transduction | 1 | 2011 | 313 |
Why?
| Beta Particles | 4 | 1986 | 3 |
Why?
| Epilepsy | 1 | 2003 | 49 |
Why?
| Monocytes | 2 | 1999 | 124 |
Why?
| Blood Vessel Prosthesis Implantation | 1 | 2001 | 24 |
Why?
| Carotid Arteries | 2 | 1998 | 51 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2002 | 104 |
Why?
| Genome-Wide Association Study | 2 | 2010 | 8 |
Why?
| Platelet-Derived Growth Factor | 2 | 1995 | 37 |
Why?
| Oxygen | 1 | 2002 | 179 |
Why?
| Vascular Diseases | 1 | 2000 | 60 |
Why?
| Transplantation Conditioning | 1 | 1999 | 23 |
Why?
| Constriction, Pathologic | 1 | 1999 | 65 |
Why?
| Aged, 80 and over | 5 | 2001 | 599 |
Why?
| Radiotherapy Dosage | 1 | 1999 | 55 |
Why?
| Graft Occlusion, Vascular | 1 | 1999 | 22 |
Why?
| Femoral Artery | 1 | 1999 | 52 |
Why?
| Cyclophosphamide | 1 | 1999 | 82 |
Why?
| Antigens, CD40 | 1 | 1998 | 24 |
Why?
| DNA Damage | 2 | 2008 | 66 |
Why?
| Wound Healing | 1 | 1999 | 106 |
Why?
| Prostatic Neoplasms | 1 | 2004 | 120 |
Why?
| Transforming Growth Factor beta1 | 2 | 2005 | 43 |
Why?
| Bone Marrow Transplantation | 1 | 1999 | 90 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 2001 | 224 |
Why?
| Pneumonia | 1 | 1998 | 85 |
Why?
| Neovascularization, Physiologic | 1 | 1998 | 68 |
Why?
| Carotid Artery, Common | 1 | 1995 | 23 |
Why?
| Membrane Glycoproteins | 1 | 1998 | 154 |
Why?
| Gamma Rays | 3 | 1996 | 38 |
Why?
| Hydroxyproline | 2 | 2002 | 16 |
Why?
| Horseradish Peroxidase | 1 | 1994 | 14 |
Why?
| Bone and Bones | 1 | 1998 | 99 |
Why?
| Cell Division | 3 | 1998 | 273 |
Why?
| Mice, Knockout | 2 | 2002 | 265 |
Why?
| Apoptosis | 2 | 2010 | 265 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 1999 | 243 |
Why?
| Rats, Inbred Strains | 1 | 1994 | 170 |
Why?
| Muscle, Skeletal | 1 | 1998 | 114 |
Why?
| Bronchoalveolar Lavage Fluid | 2 | 2002 | 68 |
Why?
| Image Processing, Computer-Assisted | 1 | 1994 | 138 |
Why?
| Transcription, Genetic | 1 | 1996 | 253 |
Why?
| Neutrophil Infiltration | 1 | 2011 | 17 |
Why?
| X-Ray Microtomography | 1 | 2011 | 14 |
Why?
| Clinical Trials as Topic | 2 | 1999 | 251 |
Why?
| Linear Energy Transfer | 1 | 2011 | 2 |
Why?
| Necrosis | 1 | 2011 | 82 |
Why?
| Spores, Fungal | 1 | 2011 | 5 |
Why?
| BH3 Interacting Domain Death Agonist Protein | 1 | 2011 | 12 |
Why?
| Microradiography | 1 | 2010 | 6 |
Why?
| bcl-2-Associated X Protein | 1 | 2011 | 40 |
Why?
| bcl-X Protein | 1 | 2011 | 32 |
Why?
| Erythroblasts | 1 | 2011 | 13 |
Why?
| Inflammation Mediators | 1 | 2011 | 56 |
Why?
| Platinum Compounds | 1 | 2010 | 7 |
Why?
| Paresthesia | 1 | 2010 | 16 |
Why?
| Renal Insufficiency | 1 | 2010 | 21 |
Why?
| Energy Transfer | 1 | 1990 | 19 |
Why?
| Electrons | 1 | 1990 | 10 |
Why?
| Body Weight | 1 | 2011 | 178 |
Why?
| Infertility, Male | 1 | 2010 | 19 |
Why?
| Employment | 1 | 2010 | 47 |
Why?
| Collagen | 2 | 1995 | 118 |
Why?
| Mice, Inbred CBA | 1 | 1990 | 41 |
Why?
| Dendritic Cells | 1 | 2011 | 60 |
Why?
| Teaching Materials | 1 | 2009 | 11 |
Why?
| Genetic Markers | 1 | 2010 | 78 |
Why?
| Population Surveillance | 1 | 2010 | 70 |
Why?
| Biophysics | 1 | 2009 | 37 |
Why?
| Accreditation | 1 | 2009 | 15 |
Why?
| Mentors | 1 | 2009 | 22 |
Why?
| Canada | 1 | 2009 | 60 |
Why?
| Pilot Projects | 1 | 2011 | 264 |
Why?
| Cell Cycle | 1 | 2011 | 121 |
Why?
| Neutrophils | 1 | 2011 | 114 |
Why?
| Terminology as Topic | 1 | 2010 | 81 |
Why?
| Fatigue | 1 | 2010 | 48 |
Why?
| Forecasting | 1 | 2009 | 147 |
Why?
| Cognition | 1 | 2010 | 97 |
Why?
| Educational Status | 1 | 2009 | 99 |
Why?
| Educational Measurement | 1 | 2009 | 60 |
Why?
| Evidence-Based Medicine | 1 | 2010 | 125 |
Why?
| Societies, Medical | 1 | 2009 | 90 |
Why?
| Neoplasms, Second Primary | 1 | 2010 | 31 |
Why?
| Endothelial Cells | 1 | 2011 | 80 |
Why?
| Prospective Studies | 2 | 2001 | 545 |
Why?
| Flow Cytometry | 1 | 2011 | 216 |
Why?
| Models, Statistical | 1 | 2010 | 114 |
Why?
| Magnetic Resonance Imaging | 1 | 1994 | 294 |
Why?
| Genetic Predisposition to Disease | 1 | 2010 | 131 |
Why?
| Neoplasm Recurrence, Local | 1 | 2010 | 118 |
Why?
| Membrane Proteins | 2 | 1998 | 233 |
Why?
| Incidence | 1 | 2010 | 336 |
Why?
| Oropharynx | 1 | 2006 | 9 |
Why?
| Practice Guidelines as Topic | 1 | 2009 | 174 |
Why?
| Quality of Life | 1 | 2010 | 188 |
Why?
| Cardiovascular Diseases | 1 | 2010 | 127 |
Why?
| Oxidative Stress | 1 | 2010 | 119 |
Why?
| Age Factors | 1 | 2009 | 480 |
Why?
| Administration, Inhalation | 1 | 2006 | 60 |
Why?
| Tomography, X-Ray Computed | 1 | 2010 | 321 |
Why?
| Risk Assessment | 1 | 2010 | 324 |
Why?
| Transforming Growth Factor beta3 | 1 | 2005 | 4 |
Why?
| Transforming Growth Factor beta2 | 1 | 2005 | 5 |
Why?
| Intubation, Intratracheal | 1 | 2006 | 50 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 121 |
Why?
| Mice, Inbred DBA | 1 | 2005 | 38 |
Why?
| Cyclooxygenase 1 | 1 | 2005 | 41 |
Why?
| ROC Curve | 1 | 2005 | 80 |
Why?
| Treatment Outcome | 2 | 2001 | 661 |
Why?
| Orchiectomy | 1 | 2004 | 23 |
Why?
| Antineoplastic Agents, Hormonal | 1 | 2004 | 30 |
Why?
| Tissue Distribution | 1 | 2004 | 124 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2003 | 35 |
Why?
| Pyrazoles | 1 | 2003 | 42 |
Why?
| Convulsants | 1 | 2003 | 10 |
Why?
| Cyclooxygenase 2 Inhibitors | 1 | 2003 | 45 |
Why?
| Androgen Antagonists | 1 | 2004 | 18 |
Why?
| Bromodeoxyuridine | 1 | 2003 | 47 |
Why?
| Interferon-gamma | 1 | 2005 | 133 |
Why?
| Dentate Gyrus | 1 | 2003 | 20 |
Why?
| Lipopolysaccharides | 1 | 2004 | 98 |
Why?
| Predictive Value of Tests | 1 | 2005 | 321 |
Why?
| Nitrobenzenes | 1 | 2002 | 20 |
Why?
| Anastomosis, Surgical | 1 | 2002 | 45 |
Why?
| Chemokine CXCL2 | 1 | 2002 | 29 |
Why?
| In Situ Nick-End Labeling | 1 | 2002 | 65 |
Why?
| Liver Neoplasms | 1 | 2004 | 97 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2002 | 42 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2002 | 31 |
Why?
| Cell Count | 1 | 2003 | 163 |
Why?
| Neoplasm Staging | 1 | 2004 | 125 |
Why?
| Cell Culture Techniques | 1 | 2002 | 74 |
Why?
| Sheep | 1 | 2001 | 46 |
Why?
| Sensitivity and Specificity | 1 | 2005 | 427 |
Why?
| In Situ Hybridization | 1 | 2002 | 135 |
Why?
| Hippocampus | 1 | 2003 | 83 |
Why?
| Vascular Patency | 1 | 2001 | 28 |
Why?
| Polytetrafluoroethylene | 1 | 2001 | 23 |
Why?
| Behavior, Animal | 1 | 2003 | 77 |
Why?
| Chemokine CCL2 | 1 | 2002 | 57 |
Why?
| Nitric Oxide Synthase | 1 | 2002 | 44 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2002 | 82 |
Why?
| Cell Line, Tumor | 1 | 2003 | 208 |
Why?
| Animals, Newborn | 1 | 2002 | 175 |
Why?
| Brain Neoplasms | 1 | 2004 | 116 |
Why?
| Lung Neoplasms | 1 | 2004 | 159 |
Why?
| Severity of Illness Index | 1 | 2004 | 358 |
Why?
| Peroxidases | 1 | 1999 | 24 |
Why?
| Angioplasty, Balloon | 1 | 2000 | 35 |
Why?
| Culture Media, Conditioned | 1 | 1999 | 45 |
Why?
| Arteriosclerosis | 1 | 2000 | 54 |
Why?
| Kinetics | 1 | 2002 | 349 |
Why?
| Mast Cells | 1 | 1998 | 31 |
Why?
| Evaluation Studies as Topic | 1 | 1999 | 178 |
Why?
| Transplantation, Homologous | 1 | 1999 | 94 |
Why?
| Laser-Doppler Flowmetry | 1 | 1998 | 18 |
Why?
| CD40 Ligand | 1 | 1998 | 51 |
Why?
| Iodine Radioisotopes | 1 | 1998 | 64 |
Why?
| Hindlimb | 1 | 1998 | 38 |
Why?
| Cricetinae | 1 | 1998 | 130 |
Why?
| Rabbits | 1 | 1999 | 252 |
Why?
| DNA Primers | 1 | 1999 | 208 |
Why?
| Retrospective Studies | 1 | 2004 | 653 |
Why?
| Regional Blood Flow | 1 | 1998 | 105 |
Why?
| Cerebrovascular Circulation | 1 | 1997 | 62 |
Why?
| Cell Adhesion | 1 | 1998 | 113 |
Why?
| Cesium Radioisotopes | 1 | 1996 | 18 |
Why?
| Thorax | 1 | 1996 | 30 |
Why?
| Disease Susceptibility | 1 | 1996 | 61 |
Why?
| Microscopy, Electron, Scanning Transmission | 1 | 1995 | 4 |
Why?
| Follow-Up Studies | 1 | 2001 | 553 |
Why?
| Immunity, Innate | 1 | 1996 | 60 |
Why?
| Cell Movement | 1 | 1998 | 163 |
Why?
| Microscopy, Electron, Scanning | 1 | 1995 | 69 |
Why?
| Fibronectins | 1 | 1995 | 57 |
Why?
| Antibodies, Monoclonal | 1 | 1998 | 241 |
Why?
| Endothelium, Vascular | 1 | 1997 | 139 |
Why?
| Neurons | 1 | 1999 | 195 |
Why?
| Stochastic Processes | 1 | 1988 | 22 |
Why?
| Swine | 1 | 1986 | 95 |
Why?
|
|
Williams's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
